We are structuring a Stage A fundraise designed to attract institutional investors, providing sufficient runway for expansion into preventive healthcare and regional scaling. At the core of this vision is Aevion Laboratories, a luxury longevity wellness centre that combines GMP-certified stem cell science with premium hospitality to serve Asia’s high-net-worth clientele.
Our stem cell technology and supply chains are already established; what we now seek is strategic investment to accelerate market development and branding, beginning with Southeast Asia where we have identified an immediate demand market.